ArticleCureus2025
Lower Serum Chloride at ICU Admission Is Associated With Acute Kidney Injury in Critically Ill Solid Tumour Patients: A Retrospective Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Acute kidney injury (AKI) is common in cancer intensive care units (ICUs) and is associated with high mortality. Although chloride plays a key role in renal haemodynamics, its clinical significance is often underemphasised. However, the relationship between serum chloride and AKI in oncological critical care remains unexplored in observational studies. Methods We analysed 846 consecutive solid tumour ICU admissions (≥3 days, 2018-2024) without AKI within 48 hours of admission. Hypochloraemia was defined as serum chloride <96 mmol/L. AKI was adjudicated using KDIGO creatinine criteria. Multivariable logistic regression and ROC analyses were performed. Results AKI developed in 416 patients (49.2%). Admission chloride was lower in those who developed AKI (97.0 ± 11.3 vs 104.0 ± 12.5 mmol/L, P < 0.001). After adjustment for illness severity (APACHE II score) and baseline renal function (eGFR), among other confounders, patients with hypochloraemia had 87% higher odds of AKI than those with normochloraemia (OR 1.87, 95% CI 1.14-2.60). Furthermore, each 1 SD decrement (11.5 mmol/L) in serum chloride raised the AKI risk by 46.5% (OR 1.465, 95% CI 1.134-1.792). Discriminative AUCs were 0.751 for any AKI and 0.819 for stage 3 AKI; optimal cut-offs (97 mmol/L and 92 mmol/L, respectively) lay at or below the reference range. Associations remained consistent across baseline estimated glomerular filtration rate strata. Conclusions Lower serum chloride is a readily identifiable and potentially modifiable predictor of AKI in critically ill solid tumour patients. The potential of real-time chloride monitoring and early repletion as low-cost AKI prevention strategies warrants prospective evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.